NCT02942407 Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT02940639 Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy Status COMPLETED Phase N/A
NCT02935634 A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT02933697 Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) Status COMPLETED Phase PHASE3
NCT02933346 Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program Status COMPLETED Phase N/A
NCT02932969 Study With Healthy Japanese and Non-Asian Participants With BMS-986231 Status COMPLETED Phase PHASE1
NCT02931838 Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE2
NCT02928263 Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents Status WITHDRAWN Phase N/A
NCT02927769 A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment Status COMPLETED Phase PHASE2
NCT02923934 A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers Status COMPLETED Phase PHASE2
NCT02922452 A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02921126 Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy Status COMPLETED Phase N/A
NCT02919683 Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02917772 Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02915159 A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome Status COMPLETED Phase PHASE3